Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. FDA has accepted a Biologic License Application submission for AVT03. Read more here.

Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK facility and provided updates on the ongoing ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens. In 2023, Civica struck a deal to produce insulin for the state of California ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

The Department of Health in KwaZulu-Natal has blamed a shortage of insulin on the global Ozempic frenzy. The medication, meant to regulate blood sugar levels, is being used as a weight-loss drug.

On March 12, 2025, a Missoula Police Department Officer responded to a report of a stolen vehicle from Cooper Street. The ...

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, March 17, 2025. Let’s take a ...